Adding Printed CBT Materials to a Pediatric Digital Intervention
Launched by NEUROMOTION LABS · Aug 29, 2024
Trial Information
Current as of June 26, 2025
Not yet recruiting
Keywords
ClinConnect Summary
This clinical trial is looking at how combining printed materials with a digital game can help children learn to manage their emotions better. The study will involve kids aged 4 to 16 who will use a video game called Mightier, which helps them understand and control their feelings by using heart rate feedback. The goal is to see if having physical materials that teach similar skills alongside the game makes a bigger difference in reducing emotional difficulties than using the game alone.
To participate, children need to be between 4 and 16 years old and have regular access to WiFi for the game. They shouldn't have used Mightier before and must choose to take part in the study on their own. Parents or caregivers will fill out a short survey before the child starts using the game and again after 12 weeks to help researchers see how well the program is working. This study is not recruiting participants yet, but it aims to better understand how different ways of learning emotional regulation can help kids improve their emotional health.
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • Age 4-16 years old at time of enrollment
- • Regular access to WiFi (for Mightier gameplay device connection)
- • Independently elected to engage with Mightier program
- Exclusion Criteria:
- • Previous use of Mightier
- • Under the age of 4
- • Older then 16 years of age
About Neuromotion Labs
Neuromotion Labs is a pioneering clinical trial sponsor dedicated to advancing neurotechnology and therapeutic solutions for neurological disorders. By leveraging cutting-edge research and innovative methodologies, the company aims to enhance patient outcomes through rigorous clinical studies that explore the efficacy and safety of novel interventions. With a commitment to collaboration and scientific excellence, Neuromotion Labs strives to bridge the gap between research and real-world application, ultimately improving the quality of life for individuals affected by neurological conditions.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Patients applied
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported